Skip to search formSkip to main contentSkip to account menu

Levalbuterol

Known as: (R)-salbutamol, (-)-Albuterol, Levosalbutamol 
A short-acting sympathomimetic beta-2 adrenergic receptor agonist with bronchodilator activity. Levalbuterol binds to beta-2 adrenergic receptors in… 
National Institutes of Health

Related topics

Related topics

18 relations
200 ACTUAT Levalbuterol 0.045 MG/ACTUAT Metered Dose Inhaler200 ACTUAT Levalbuterol 0.045 MG/ACTUAT Metered Dose Inhaler [Xopenex]Adrenergic beta2-Agonists [MoA]Albuterol

Narrower (3)

Levalbuterol HydrochlorideXopenexlevalbuterol tartrate

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2006
2006
Levalbuterol Inhibits Human Airway Smooth Muscle Cell Proliferation: Therapeutic Implications in the Management of Asthma
Background: Racemic albuterol is a mixture of (R)- and (S)-enantiomers of albuterol. Its pharmacological activity and clinical… 
2005
2005
Levalbuterol Versus Racemic Albuterol in the Treatment of Acute Exacerbation of Asthma in Children
Objective: To compare levalbuterol and racemic albuterol for the treatment of acute exacerbation of asthma in pediatric… 
2004
2004
COMPARISON OF RACEMIC ALBUTEROL AND LEVALBUTEROL FOR TREATMENT OF ACUTE ASTHMA
Carl JC, Myers TR, Kirchner L, et al. J Pediatr. 2003;143:731–736 Inhaled β-receptor agonists are widely used to treat… 
2004
2004
Influenza-induced tachypnea is prevented in immune cotton rats, but cannot be treated with an anti-inflammatory steroid or a neuraminidase inhibitor.
2003
2003
Changes in heart rate associated with nebulized racemic albuterol and levalbuterol in intensive care patients.
The effects of equipotent doses of racemic albuterol and levalbuterol on heart rate (HR) in intensive care patients with and… 
Review
2000
Review
2000
Levalbuterol Nebulizer Solution: Is It Worth Five Times the Cost of Albuterol?
Albuterol is a 50:50 mixture of R‐albuterol, the active enantiomer, and S‐albuterol, which appears to be inactive in humans. The… 
Highly Cited
1999
Highly Cited
1999
Bronchoprotective and bronchodilator effects of single doses of (S)-salbutamol, (R)-salbutamol and racemic salbutamol in patients with bronchial asthma
AbstractObjectives: The drug salbutamol is used as a 50: 50 racemic mixture of its two enantiomers, (R)- and (S)-salbutamol… 
Highly Cited
1999
Highly Cited
1999
The asthma-like pharmacology and toxicology of (S)-isomers of β agonists☆☆☆
1999
1999
Tolerance to the bronchoprotective effect of beta2-agonists: comparison of the enantiomers of salbutamol with racemic salbutamol and placebo.
1997
1997
(-)-salbutamol sulphation in the human liver and duodenal mucosa: interindividual variability.
1. Salbutamol as a beta 2-adrenergic agonist used in the treatment of lung obstructive disease and premature labour. It has a… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)